10-Q 1 c57572_10-q.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 


 

 

(Mark One)

 

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934


 

 

For the quarterly period ended

March 31, 2009

 


 

 

or


 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


 

 

For the transition period from ________________________________________ to ______________________________________

 

 

Commission File Number

0-12944

 



 

ZYGO CORPORATION


(Exact name of registrant as specified in its charter)


 

 

 

Delaware

06-0864500

 




(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

 

 

Laurel Brook Road, Middlefield, Connecticut

06455

 




(Address of principal executive offices)

(Zip Code)

 

 

 

 

(860) 347-8506


Registrant’s telephone number, including area code

 

N/A


(Former name, former address, and former fiscal year, if changed from last report)


 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (1)                                                                                                                                                                o YES x NO

 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                                                                                                                                                           o YES x NO

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer o

Accelerated filer x

Non-accelerated filer o (Do not check if a smaller reporting company)

Smaller reporting company o


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
o YES x NO

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

16,892,569 shares of Common Stock, $.10 Par Value, at May 1, 2009

1


(1) In connection with its previously disclosed acquisition of the assets of Solvision, Inc., the registrant was required to file stand-alone audited financial statements for Solvision, Inc. for each of its last two fiscal years, within 75 days of such acquisition (or by May 13, 2008). The registrant has filed such audited financial statements in an 8-K/A with the SEC on December 5, 2008.

FORWARD LOOKING STATEMENTS

All statements other than statements of historical fact included in this Form 10-Q Quarterly Report regarding our financial performance, condition and operations, and the business strategy, plans, anticipated sales, orders, market acceptance, growth rates, market opportunities, and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements are intended to provide management’s current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plans,” “strategy,” “project,” and other words of similar meaning in connection with a discussion of future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending of our customers; fluctuations in net sales to our major customer; manufacturing and supplier risks; risks of order cancellations, push-outs and de-bookings; dependence on timing and market acceptance of new product development; rapid technological and market change; risks in international operations; dependence on proprietary technology and key personnel; length of the sales cycle; environmental regulations; investment portfolio returns; fluctuations in our stock price; and the risk that anticipated growth opportunities may be smaller than anticipated or may not be realized.

Any forward-looking statements included in this Quarterly Report speak only as of the date of this document. We undertake no obligation to publicly update or revise forward-looking statements to reflect events or circumstances occurring after the date of this Form 10-Q. Further information on potential factors that could affect our business is described in our reports on file with the Securities and Exchange Commission, including our Form 10-K, as amended by Form 10-K/A, for the fiscal year ended June 30, 2008.

2


PART I - Financial Information

Item 1. Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(Thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

20,031

 

$

38,456

 

$

91,873

 

$

110,539

 

Cost of goods sold

 

 

16,875

 

 

22,907

 

 

59,650

 

 

67,292

 

 

 



 



 



 



 

Gross profit

 

 

3,156

 

 

15,549

 

 

32,223

 

 

43,247

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expenses

 

 

15,959

 

 

9,328

 

 

37,927

 

 

24,577

 

Research, development, and engineering expenses

 

 

7,008

 

 

6,248

 

 

18,419

 

 

17,353

 

Provision for doubtful accounts and notes

 

 

15

 

 

(37

)

 

1,014

 

 

1,523

 

 

 



 



 



 



 

Operating profit (loss)

 

 

(19,826

)

 

10

 

 

(25,137

)

 

(206

)

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

140

 

 

517

 

 

800

 

 

1,998

 

Miscellaneous income (expense)

 

 

(220

)

 

(394

)

 

104

 

 

82

 

 

 



 



 



 



 

Total other income (expense)

 

 

(80

)

 

123

 

 

904

 

 

2,080

 

 

 



 



 



 



 

Earnings (loss) before income taxes and minority interest

 

 

(19,906

)

 

133

 

 

(24,233

)

 

1,874

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax (expense) benefit

 

 

4,908

 

 

(15

)

 

6,345

 

 

(642

)

Minority interest

 

 

(103

)

 

(167

)

 

(751

)

 

(1,046

)

 

 



 



 



 



 

Net earnings (loss)

 

$

(15,101

)

$

(49

)

$

(18,639

)

$

186

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic - Earnings (loss) per share

 

$

(0.90

)

$

(0.00

)

$

(1.11

)

$

0.01

 

 

 



 



 



 



 

Diluted - Earnings (loss) per share

 

$

(0.90

)

$

(0.00

)

$

(1.11

)

$

0.01

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

 

16,872

 

 

16,751

 

 

16,826

 

 

17,482

 

 

 



 



 



 



 

Diluted shares

 

 

16,872

 

 

16,751

 

 

16,826

 

 

17,819

 

 

 



 



 



 



 

See accompanying notes to condensed consolidated financial statements.

3


CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(Thousands, except share amounts)

 

 

 

 

 

 

 

 

 

 

March 31, 2009

 

June 30, 2008

 

 

 


 


 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

35,726

 

$

26,421

 

Marketable securities

 

 

6,975

 

 

17,639

 

Receivables, net of allowance for doubtful accounts of $454 and $349, respectively

 

 

20,278

 

 

31,036

 

Inventories

 

 

38,490

 

 

37,542

 

Prepaid expenses and other

 

 

1,760

 

 

2,230

 

Income tax receivable

 

 

836

 

 

241

 

Deferred income taxes

 

 

5,273

 

 

12,143

 

 

 



 



 

Total current assets

 

 

109,338

 

 

127,252

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

365

 

 

6,963

 

Property, plant, and equipment, net

 

 

34,724

 

 

36,371

 

Deferred income taxes

 

 

23,547

 

 

8,904

 

Intangible assets, net

 

 

7,326

 

 

9,522

 

Other assets

 

 

1,013

 

 

996

 

 

 



 



 

Total assets

 

$

176,313

 

$

190,008

 

 

 



 



 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

6,119

 

$

7,955

 

Accrued progress payments

 

 

7,616

 

 

5,226

 

Accrued salaries and wages

 

 

3,228

 

 

4,156

 

Other accrued liabilities

 

 

10,553

 

 

5,032

 

Deferred income taxes

 

 

226

 

 

32

 

 

 



 



 

Total current liabilities

 

 

27,742

 

 

22,401

 

 

 

 

 

 

 

 

 

Long-term income tax payable

 

 

1,826

 

 

1,973

 

Other long-term liabilities

 

 

920

 

 

844

 

Minority interest

 

 

1,294

 

 

1,844

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

Common stock, $0.10 par value per share:

 

 

 

 

 

 

 

40,000,000 shares authorized;
18,991,713 shares issued (18,824,670 at June 30, 2008);
16,879,630 shares outstanding (16,732,399 at June 30, 2008)

 

 

1,899

 

 

1,882

 

Additional paid-in capital

 

 

155,362

 

 

152,663

 

Retained earnings

 

 

13,875

 

 

32,514

 

Accumulated other comprehensive income (loss):

 

 

 

 

 

 

 

Currency translation effects

 

 

(1,053

)

 

1,277

 

 

 



 



 

 

 

 

170,083

 

 

188,336

 

Less treasury stock, at cost, 2,112,083 shares (2,092,271 at June 30, 2008

 

 

25,552

 

 

25,390

 

 

 



 



 

Total stockholders’ equity

 

 

144,531

 

 

162,946

 

 

 



 



 

Total liabilities and stockholders’ equity

 

$

176,313

 

$

190,008

 

 

 



 



 

See accompanying notes to condensed consolidated financial statements.

4


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(Thousands of dollars)

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2009

 

2008

 

 

 


 


 

Cash provided by operating activities:

 

 

 

 

 

 

 

Net earnings (loss)

 

$

(18,639

)

$

186

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net earnings (loss) to cash provided by (used for) operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

6,157

 

 

5,378

 

Deferred income taxes

 

 

(7,807

)

 

(669

)

Impairment of marketable securities

 

 

309

 

 

291

 

Loss on disposal and impairment of intangible assets

 

 

2,361

 

 

 

Compensation cost related to share-based payments arrangements

 

 

2,324

 

 

1,989

 

Excess tax benefits from share-based payment arrangements

 

 

(9

)

 

(40

)

Minority interest

 

 

751

 

 

1,267

 

Provision for doubtful accounts and notes receivable

 

 

1,016

 

 

1,519

 

Other, net

 

 

(390

)

 

(916

)

Changes in operating accounts:

 

 

 

 

 

 

 

Receivables

 

 

10,351

 

 

5,907

 

Inventories

 

 

(1,717

)

 

4,582

 

Prepaid expenses and other current assets

 

 

(129

)

 

(117

)

Accounts payable, accrued expenses, and taxes payable

 

 

5,212

 

 

(9,436

)

 

 



 



 

Net cash provided (used for) by operating activities

 

 

(210

)

 

9,941

 

 

 



 



 

Cash provided by investing activities:

 

 

 

 

 

 

 

Additions to property, plant, and equipment

 

 

(4,251

)

 

(5,683

)

Issuance of note receivable

 

 

 

 

(1,500

)

Investments and acqusitions, excluding cash acquired

 

 

 

 

(4,138

)

Purchase of marketable securities

 

 

(8,174

)

 

(4,963

)

Additions to intangibles and other assets

 

 

(840

)

 

(622

)

Proceeds from the maturity and sale of marketable securities

 

 

24,862

 

 

30,938

 

 

 



 



 

Net cash provided by investing activities

 

 

11,597

 

 

14,032

 

 

 



 



 

Cash used for financing activities:

 

 

 

 

 

 

 

Employee stock purchase

 

 

207

 

 

267

 

Repurchase of common stock

 

 

 

 

(20,049

)

Dividend payment to minority interest

 

 

(1,301

)

 

(751

)

Exercise of employee stock options

 

 

185

 

 

487

 

Vesting of restricted stock and related tax benefits

 

 

(162

)

 

(88

)

Excess tax benefits from share-based payment arangements

 

 

9

 

 

40

 

 

 



 



 

Net cash used for financing activities

 

 

(1,062

)

 

(20,094

)

 

 



 



 

Effect of exchange rate changes on cash and cash equivalents

 

 

(1,020

)

 

754

 

 

 



 



 

Net increase in cash and cash equivalents

 

 

9,305

 

 

4,633

 

Cash and cash equivalents, beginning of period

 

 

26,421

 

 

17,826

 

 

 



 



 

Cash and cash equivalents, end of period

 

$

35,726

 

$

22,459

 

 

 



 



 

Supplemental Cash Flow Information

Net income tax payments amounted to $1,150 and $2,101 for the nine months ended March 31, 2009 and 2008, respectively.

See accompanying notes to condensed consolidated financial statements.

5


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except for per share amounts)

Note 1: Principles of Consolidation and Presentation

Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics, and electro-optical design and manufacturing services, serving customers in the semiconductor capital equipment and industrial markets. The accompanying condensed consolidated financial statements include the accounts of Zygo Corporation and its subsidiaries (“ZYGO,” “we,” “us,” “our” or “the Company”). The Company follows accounting principles generally accepted in the United States of America. ZYGO’s reporting currency is the U.S. dollar. The functional currency of the majority of our foreign subsidiaries is their local currency and, as such, amounts included in the consolidated statements of operations are translated at the weighted-average exchange rates for the period. Assets and liabilities are translated at period-end exchange rates and resulting foreign exchange translation adjustments are recorded in the consolidated balance sheets as a component of accumulated other comprehensive income (loss). All transactions and accounts with the subsidiaries have been eliminated from the condensed consolidated financial statements. The results of operations for the three and nine months ended March 31, 2009 are not necessarily indicative of the results to be expected for the full fiscal year.

The Condensed Consolidated Balance Sheet at March 31, 2009, the Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2009 and 2008, and the Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2009 and 2008 are unaudited but, in management’s opinion, include all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of the results of the interim periods. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K, as amended by Form 10-K/A, for the year ended June 30, 2008, including items incorporated by reference therein.

Revenue Recognition

ZYGO recognizes revenue based on guidance provided in SEC Staff Accounting Bulletin (“SAB”) No. 104, “Revenue Recognition,” and in accordance with Emerging Issues Task Force (“EITF”) Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables.” ZYGO recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, ZYGO’s price is fixed or determinable, and collectability is reasonably assured. ZYGO recognizes revenue on its standard products when title passes to the customer upon shipment. While ZYGO’s standard products generally require installation, the installation is considered a perfunctory performance obligation. The standard products do not have customer acceptance criteria. Generally, software is a component of ZYGO’s standard product and, as such, is not separately recognized as revenue. Standalone software products are recognized as revenue when they are shipped. ZYGO has standard rights of return which relate to defective products under warranty that ZYGO accounts for as a warranty provision under SFAS No. 5, “Accounting for Contingencies.”

ZYGO does not have any price protection agreements or other post shipment obligations. For custom equipment where customer acceptance is part of the sales agreement, revenue is recognized when the customer has accepted the product. In cases where custom equipment does not have customer acceptance as part of the sales agreement, ZYGO recognizes revenue upon shipment, as long as the system meets the specifications as agreed upon with the customer. Certain transactions have multiple deliverables, with the deliverables clearly defined. To the extent that the secondary deliverables are other than perfunctory, ZYGO recognizes the revenue on each deliverable, if separable, or on the completion of all deliverables, if not separable. Revenue generated from development contracts are recorded on a cost-plus basis in the period services are rendered.

Certain customer transactions include payment terms whereby ZYGO receives a partial payment of the total order amount prior to the related sale being recognized in its financial statements. These advance payments are included in accrued progress payments in the consolidated balance sheet. Generally, these progress payments relate to orders for custom equipment that require a lengthy build cycle and, in some cases, acceptance by the customer. ZYGO may negotiate payment terms with these customers on these particular orders and secure certain payments prior to or on shipment of the equipment. These payments remain in accrued progress payments until ZYGO’s applicable revenue recognition criteria have been met.

6


Note 2: Earnings Per Share

Basic and diluted earnings per share are calculated in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 128, “Earnings Per Share.” For the three and nine months ended March 31, 2009, 2,486,612 and 2,403,324, respectively, (for the three and nine months ended March 31, 2008, 2,713,509 and 1,153,480, respectively) of the Company’s outstanding stock options and restricted stock awards (“Stock Grants”) were excluded from the calculation of diluted earnings per share because they were antidilutive.

The following table sets forth the reconciliation of basic weighted average shares outstanding and diluted weighted average shares outstanding for the periods presented:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

Basic weighted average shares outstanding

 

 

16,872,396

 

 

16,751,243

 

 

16,826,303

 

 

17,481,825

 

Dilutive effect of stock options and restricted shares

 

 

 

 

 

 

 

 

337,385

 

 

 



 



 



 



 

Diluted weighted average shares outstanding

 

 

16,872,396

 

 

16,751,243

 

 

16,826,303

 

 

17,819,210

 

 

 



 



 



 



 

Note 3: Recent Accounting Pronouncements

In April 2009, the FASB issued FSP FAS 157-4, “Determining Fair Value When Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly” (FSP 157-4). FSP 157-4 provides guidance on how to determine the fair value of assets and liabilities when the volume and level of activity for the asset/liability has significantly decreased. FSP 157-4 also provides guidance on identifying circumstances that indicate a transaction is not orderly. In addition, FSP 157-4 requires disclosure in interim and annual periods of the inputs and valuation techniques used to measure fair value and a discussion of changes in valuation techniques. FSP 157-4 is effective for us beginning in the fourth quarter of fiscal year 2009. The adoption of FSP 157-4 is not expected to have a significant impact on our consolidated financial statements.

In April 2009, the FASB issued FSP FAS 115-2 and FAS 124-2, “Recognition and Presentation of Other-Than-Temporary Impairment” (FSP 115-2/124-2). FSP 115-2/124-2 amends the requirements for the recognition and measurement of other-than-temporary impairments for debt securities by modifying the pre-existing “intent and ability” indicator. Under FSP 115-2/124-2, an other-than-temporary impairment is triggered when there is an intent to sell the security, it is more likely than not that the security will be required to be sold before recovery, or the security is not expected to recover the entire amortized cost basis of the security. Additionally, FSP 115-2/124-2 changes the presentation of an other-than-temporary impairment in the income statement for those impairments involving credit losses. The credit loss component will be recognized in earnings and the remainder of the impairment will be recorded in other comprehensive income. FSP 115-2/124-2 is effective for us beginning in the fourth quarter of fiscal year 2009. Upon implementation at the beginning of the fourth quarter of 2009, FSP 115-2/124-2 is not expected to have a significant impact on our consolidated financial statements.

In April 2009, the FASB issued FSP FAS 107-1 and APB 28-1, “Interim Disclosure about Fair Value of Financial Instruments” (FSP 107-1/APB 28-1). FSP 107-1/APB 28-1 requires interim disclosures regarding the fair values of financial instruments that are within the scope of FAS 107, “Disclosures about the Fair Value of Financial Instruments.” Additionally, FSP 107-1/APB 28-1 requires disclosure of the methods and significant assumptions used to estimate the fair value of financial instruments on an interim basis as well as changes of the methods and significant assumptions from prior periods. FSP 107-1/APB 28-1 does not change the accounting treatment for these financial instruments and is effective for us beginning in the fourth quarter of fiscal year 2009.

7


On July 1, 2008 we adopted the provisions of Statement of Financial Accounting Standards No. 157, “Fair Value Measurements” (“SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. The adoption of the provisions of SFAS 157 is not expected to have a material effect on us. In February 2008, the Financial Accounting Standards Board (“FASB”) issued FASB Staff Position FAS 157-1, Application of SFAS No. 157 to SFAS No. 13 and Its Related Interpretative Accounting Pronouncements that Address Leasing Transactions (“FSP No. 157-1”) and FASB Staff Position FAS 157-2, Effective Date of SFAS No. 157 (“FSP No. 157-2”). FSP No. 157-1 excludes SFAS No. 13, Accounting for Leases, and its related interpretive accounting pronouncements that address leasing transactions, with the exception of fair value measurements of assets and liabilities recorded as a result of a lease transaction but measured pursuant to other pronouncements within the scope of SFAS No. 157. FSP No. 157-2 delays the effective date of SFAS No. 157 for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). FSP No. 157-1 and FSP No. 157-2 became effective for us upon adoption of SFAS No. 157. In October 2008, the FASB issued FASB Staff Position No. 157-3, Determining the Fair Value of a Financial Asset When the Market for That Asset is Not Active (“FSP No. 157-3”). FSP No. 157-3 clarifies the application of SFAS No. 157 in cases where a market is not active. The Company has considered FSP No. 157-3 in its determination of estimated fair values as of March 31, 2009, and the impact was not material.

On July 1, 2008 we adopted the provisions of SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value, with unrealized gains and losses related to these financial instruments reported in earnings at each subsequent reporting date. We have chosen not to measure any other financial instrument or other items at fair value that are not currently required to be measured at fair value.

In April 2008, the FASB issued Staff Position (FSP) No. FAS 142-3, “Determination of the Useful Life of Intangible Assets”. The FSP amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS 142, “Goodwill and Other Intangible Assets”. The FSP is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those fiscal years. We are in the process of evaluating the impact FSP 142-3 may have on our consolidated financial statements.

In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133” (“SFAS 161”). SFAS 161 requires disclosures of how and why an entity uses derivative instruments, how derivative instruments and related hedged items are accounted for and how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. SFAS 161 is effective for us in the third quarter of fiscal 2009. The adoption of SFAS 161 did not have a material effect on our consolidated financial statements.

In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51” (“SFAS 160”). SFAS 160 requires that the ownership interests in subsidiaries held by parties other than the parent be clearly identified, labeled, and presented in the consolidated balance sheets within equity, but separate from the parent’s equity. Furthermore, the amount of consolidated net income attributable to the parent and to the non-controlling interest must be clearly identified and presented on the face of the consolidated statement of operations. The provisions of SFAS 160 are effective for our fiscal year beginning July 1, 2009. We are in the process of evaluating the impact SFAS 160 may have on our consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141R, “Business Combinations” (“SFAS 141R”). SFAS 141R offers specific guidance on how the acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any non-controlling interest in the acquirer, and goodwill acquired or any bargain purchase gains. The provisions of SFAS 141R are effective for our fiscal year beginning July 1, 2009. We are in the process of evaluating the impact SFAS 141R may have on our consolidated financial statements.

8


Note 4. Fair Value Measurements

The Company adopted SFAS No. 157 and SFAS No. 159 effective July 1, 2008 and did not elect the fair value option for its financial instruments with the exception of the application of the statement to non-recurring non-financial assets and non-financial liabilities. Non-recurring non-financial assets and non-financial liabilities for which the Company has not applied the provisions of SFAS No. 157 include those initially measured at fair value in a business combination. SFAS No. 157 defines fair value, establishes a framework for measuring fair value and expands the related disclosure requirements. The statement indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability. SFAS No. 157 defines fair value based upon an exit price model.

SFAS No. 157 establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the management’s assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of March 31, 2009:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value measurements at March 31, 2009

 

 

 

 

 

 


 

 

 

Total carrying
value at
31-Mar-09

 

Quoted prices
in active
markets
(Level 1)

 

Significant
other
observable
inputs
(Level 2)

 

Significant
unobservable
inputs
(Level 3)

 

 

 


 


 


 


 

Trading securities

 

$

365

 

$

365

 

$

 

$

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

Foreign currency hedge

 

 

43

 

 

 

 

43

 

 

 

 

 



 



 



 



 

Total

 

$

408

 

$

365

 

$

43

 

$

 

 

 



 



 



 



 

When available, the Company uses quoted market prices to determine the fair value of its marketable securities included in Level 1. When quoted market prices are unobservable, the Company uses quotes from independent pricing vendors based on recent trading activity and other relevant information. For the period from July 1, 2008 to March 31, 2009, the Level 3 asset, an auction rate security, was reduced from $270 to $0 as the result of an other than temporary impairment. There were no other activities in Level 3 fair value measurements during the period.

The carrying value of other financial instruments, including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value due to their short maturities. The remainder of our marketable securities at March 31, 2009 are accounted for as held-to-maturity investments and are recorded at amortized cost of $6,975.

Note 5: Acquisition

On February 28, 2008, we acquired certain assets of Solvision Inc. (“Solvision”), a Canadian-based company, including the shares of its Singapore subsidiary, for $4,138 in cash (net of cash received). With this acquisition, we entered the market for in-line inspection of Flip Chip Substrates and Packaged Integrated Circuits. The Consolidated Financial Statements included the results of operations of Solvision from the date of acquisition. Solvision is included in the Metrology Solutions segment.

Previously, in October 2007, we loaned $1,500 to Solvision. In December 2007, based on Solvision’s financial difficulty at the time, we recorded a reserve against the full value of the note receivable of $1,500. Based on the preliminary valuation, $941 of the note receivable was recovered as of June 30, 2008 as part of additional purchase consideration. In the first quarter of fiscal 2009, the valuation was adjusted and resulted in a loss of $266 on the portion of the note receivable previously recovered. In the second quarter of fiscal 2009, the purchase price allocation was completed and based on the final valuation a further loss of $658 was taken against the portion of the note receivable previously recovered. In the third quarter of fiscal 2009, net intangible assets of $2,149 related to the Solvision acquisition were written off as they were determined to be impaired.

9


Note 6: Share-Based Payments

We recorded share-based compensation expense for the three months ended March 31, 2009 and 2008 of $672 and $687, respectively, with a related tax benefit of $242 and $247, respectively. Share-based compensation expense for the nine months ended March 31, 2009 and 2008 was $2,324 and $1,989, respectively, with a related tax benefit of $836 and $716, respectively.

Stock Options

We utilized the Black-Scholes valuation method to determine the weighted average fair value of the stock option grants for both fiscal 2009 and 2008 stock option valuations. The key assumptions for this valuation method include the expected term of the option, stock price volatility, risk-free interest rate, dividend yield, exercise price, and forfeiture rate. Many of these assumptions are judgmental and highly sensitive in the determination of compensation expense. Under the assumptions indicated below, the weighted-average fair value of stock option grants for the three months ended March 31, 2008 were $4.64. During the three months ended March 31, 2009, there were no stock option grants. The weighted-average fair value of stock option grants for the nine months ended March 31, 2009 and 2008 was $4.43 and $4.99, respectively. The table below indicates the key assumptions used in the option valuation calculations for options granted in the periods presented and a discussion of our methodology for developing each of the assumptions used in the valuation model:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

Term

 

 

 

 

4.0 Years

 

 

4.6 Years

 

 

4.0 Years

 

Volatility

 

 

 

 

45.7

%

 

45.5

%

 

45.7

%

Dividend yield

 

 

 

 

0.0

%

 

0.0

%

 

0.0

%

Risk-free interest rate

 

 

 

 

2.5

%

 

2.9

%

 

2.5%-4.2

%

Forfeiture rate

 

 

 

 

11.0

%

 

9.5

%

 

11.0

%

Term – This is generally the period of time over which the options granted are expected to remain outstanding. Options granted have a maximum term of ten years. An increase in the expected term will increase compensation expense.

Volatility – This is a measure of the amount by which a price has fluctuated or is expected to fluctuate. Volatilities are based on implied volatilities from traded options of ZYGO’s shares, historical volatility of ZYGO’s shares, and other factors, such as expected changes in volatility arising from planned changes in ZYGO’s business operations. An increase in the expected volatility will increase compensation expense.

Dividend Yield – We did not make any dividend payments during the last five fiscal years and we have no plans to pay dividends in the foreseeable future. An increase in the dividend yield will decrease compensation expense.

Risk-Free Interest Rate – This is the U.S. Treasury rate for the week of the grant having a term equal to the expected term of the option. An increase in the risk-free interest rate will increase compensation expense.

Forfeiture Rate – This is the estimated percentage of options granted that are expected to be forfeited or canceled before becoming fully vested. An increase in the forfeiture rate will decrease compensation expense.

Restricted Stock

Our share-based compensation expense also includes the effects of the issuance of restricted stock and restricted stock units. The compensation expense related to restricted stock awards is determined based on the market price of our stock at the date of grant applied to the total number of shares that are anticipated to fully vest, which is then amortized over the expected term. During the three months ended March 31, 2009, there were no grants of restricted stock. During the three months ended March 31, 2008, an aggregate of 116,000 shares of restricted stock units were issued at a weighted average grant price of $11.10. During the nine months ended March 31, 2009 and 2008, there were an aggregate of 156,700 and 317,550 shares of restricted stock units issued at a weighted average grant price $10.68 and $11.74, respectively. Generally, the restrictions on the restricted stock and restricted stock units granted to employees lapse at a rate of 50% after three years and the remaining 50% after the fourth year.

10


Note 7: Comprehensive Loss

Total comprehensive income (loss) was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

Net earnings (loss)

 

$

(15,101

)

$

(49

)

$

(18,639

)

$

186

 

Unrealized gain on marketable securities, net of tax

 

 

 

 

 

 

39

 

 

 

Foreign currency translation effect

 

 

(850

)

 

722

 

 

(2,369

)

 

1,243

 

 

 



 



 



 



 

Comprehensive income (loss)

 

$

(15,951

)

$

673

 

$

(20,969

)

$

1,429

 

 

 



 



 



 



 

Note 8: Inventories

Inventories are stated at the lower of cost (determined on a first-in, first-out basis) or market. At March 31, 2009 and June 30, 2008, inventories were as follows:

 

 

 

 

 

 

 

 

 

 

March 31,
2009

 

June 30,
2008

 

 

 


 


 

Raw materials and manufactured parts

 

$

19,071

 

$

17,049

 

Work in process

 

 

15,357

 

 

14,763

 

Finished goods

 

 

4,062

 

 

5,730

 

 

 



 



 

 

 

$

38,490

 

$

37,542

 

 

 



 



 

Note 9: Property, Plant, and Equipment

Property, plant, and equipment are stated at cost. Maintenance and repairs are charged to expense as incurred. Management evaluates, on an ongoing basis, the carrying value of our property, plant, and equipment and makes adjustments when impairments are identified. Depreciation is based on the estimated useful lives of the various classes of assets and is computed using the straight-line method. At March 31, 2009 and June 30, 2008, property, plant, and equipment were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,
2009

 

June 30,
2008

 

Estimated Useful Life
(Years)

 

 

 


 


 


 

Land

 

$

615

 

$

615

 

 

Building and improvements

 

 

17,381

 

 

17,270

 

15-40

 

Machinery, equipment, and office furniture

 

 

62,652

 

 

62,940

 

3-8

 

Leasehold improvements

 

 

910

 

 

903

 

1-5

 

Construction in progress

 

 

1,945

 

 

2,050

 

 

 

 



 



 

 

 

 

 

 

 

83,503

 

 

83,778

 

 

 

 

Accumulated depreciation

 

 

(48,779

)

 

(47,407

)

 

 

 

 

 



 



 

 

 

 

 

 

$

34,724

 

$

36,371

 

 

 

 

 

 



 



 

 

 

 

Depreciation expense was $1,835 and $1,668 for the three months ended March 31, 2009 and 2008, respectively, and $5,566 and $5,154 for the nine months ended March 31, 2009 and 2008, respectively.

11


Note 10: Intangible Assets

Intangible assets include patents, trademarks, customer relationships and technology, and a covenant not-to-compete. The cost of patents, trademarks, customer relationships and technology is amortized on a straight-line basis over estimated useful lives ranging from 5-17 years. We entered into a non-compete agreement with a former officer and current director of the company effective February 28, 2009. The agreement calls for payments over a four year period of declining amounts totaling $878, which includes $27 of imputed interest. As of March 31, 2009, current liabilities include $205 and long-term liabilities include $313 related to the payments under this agreement. We are amortizing the value of the non-compete over four years on a declining balance method.

Intangible assets, at cost, at March 31, 2009 and June 30, 2008 were as follows:

 

 

 

 

 

 

 

 

 

 

March 31,
2009

 

June 30,
2008

 

 

 


 


 

Patents and trademarks

 

$

8,481

 

$

8,106

 

Customer relationships and technology

 

 

 

 

3,311

 

Covenant not-to-compete

 

 

851

 

 

 

 

 



 



 

 

 

 

9,332

 

 

11,417

 

Accumulated amortization

 

 

(2,006

)

 

(1,895

)

 

 



 



 

Total

 

$

7,326

 

$

9,522

 

 

 



 



 

Intangible amortization expense was $199 and $166 for the three months ended March 31, 2009 and 2008, respectively, and $574 and $335 for the nine months ended March 31, 2009 and 2008, respectively. This amortization expense related to certain intangible assets is included in Cost of goods sold in the Condensed Consolidated Statements of Operations. During the quarter ended March 31, 2009, $2,149 of customer relationships and technology intangible assets related to the Solvision asset acquisition were written off. The write-off of customer and technology related intangible assets is due to the downturn in orders to such an extent that the inherent value of the intangible asset is no longer realizable.

Intangible amortization is expected to be approximately $738, $659, $577, $492, and $420 annually in fiscal 2010-2014, respectively.

Note 11: Warranty

A limited warranty is provided on our products for periods ranging from 3 to 24 months and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires management to make estimates of product return rates and expected costs to repair or replace products under warranty. If actual return rates or repair and replacement costs, or both, differ significantly from management’s estimates, adjustments to the expense will be required.

The following is a reconciliation of the accrued warranty liability, which is included in the Other accrued liabilities in the Condensed Consolidated Balance Sheets:

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2009

 

2008

 

 

 


 


 

Beginning balance

 

$

1,263

 

$

1,552

 

Reductions for payments made

 

 

(749

)

 

(1,268

)

Changes in accruals related to pre-existing warranties

 

 

(122

)

 

(158

)

Changes in accruals related to warranties made in the current period

 

 

892

 

 

1,091

 

 

 



 



 

Ending balance

 

$

1,284

 

$

1,217

 

 

 



 



 

12


Note 12: Segment Information

ZYGO’s Metrology Solutions division (segment) consists of OEM and in-line products primarily for the semiconductor and industrial markets. The Optical Systems division (segment) consists of components and opto-mechanical assemblies primarily for the medical, defense, and aerospace industries, which are included in the industrial market. For the three and nine months ended March 31, 2009 and 2008, segment sales and gross profit are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

Metrology Solutions

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

13,933

 

$

24,337

 

$

66,086

 

$

73,491

 

Gross profit

 

$

2,493

 

$

11,285

 

$

27,034

 

$

33,508

 

Gross profit as a % of sales

 

 

18

%

 

46

%

 

41

%

 

46

%

Optical Systems

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

6,098

 

$

14,119

 

$

25,787

 

$

37,048

 

Gross profit

 

$

663

 

$

4,264

 

$

5,189

 

$

9,739

 

Gross profit as a % of sales

 

 

11

%

 

30

%

 

20

%

 

26

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

20,031

 

$

38,456

 

$

91,873

 

$

110,539

 

Gross profit

 

$

3,156

 

$

15,549

 

$

32,223

 

$

43,247

 

Gross profit as a % of sales

 

 

16

%

 

40

%

 

35

%

 

39

%

Separate financial information by segment for total assets, capital expenditures, and depreciation and amortization is not evaluated by our chief operating decision-maker. Substantially all of our operating expenses, assets, and depreciation and amortization are U.S. based.

Sales by geographic area were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

Americas

 

$

10,276

 

$

20,083

 

$

44,030

 

$

53,345

 

Europe

 

 

2,526

 

 

4,129

 

 

11,209

 

 

15,331

 

Japan

 

 

4,164

 

 

10,529

 

 

21,853

 

 

31,090

 

Pacific Rim

 

 

3,065

 

 

3,715

 

 

14,781

 

 

10,773

 

 

 



 



 



 



 

Total

 

$

20,031

 

$

38,456

 

$

91,873

 

$

110,539

 

 

 



 



 



 



 

Note 13: Transactions with Stockholder

Sales to Canon Inc., a stockholder, and Canon Sales Co., Inc., a distributor of certain of our products in Japan and a subsidiary of Canon Inc. (collectively referred to as “Canon”), amounted to $2,991 and $15,112 (15% and 16% of net sales, respectively) for the three and nine months ended March 31, 2009, respectively, as compared with $8,302 and $20,605 (22% and 19% of net sales, respectively) for the three and nine months ended March 31, 2008. Selling prices of products sold to Canon are based, generally, on the terms customarily given to distributors. At March 31, 2009 and June 30, 2008, there were, in the aggregate, $166 and $3,032, respectively, of trade accounts receivable from Canon.

13


Note 14: Derivatives and Hedging Activities

In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133” (“SFAS 161”). SFAS 161 requires entities to provide enhanced disclosure about how and why the entity uses derivative instruments, how the instruments and related hedged items are accounted for under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”), and how the instruments and related hedged items affect the financial position, results of operations, and cash flows of the entity. We adopted SFAS 161 during the quarter ended March 31, 2009.

We enter into foreign currency forward contracts to reduce the impact of adverse fluctuations on earnings associated with foreign currency exchange rate changes. We do not enter into any derivative transactions for speculative purposes. These contracts are not designated as cash flow, fair value, or net investment hedges under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended, and, therefore, are marked-to-market with changes in fair value recorded in the Condensed Consolidated Statement of Operations. These contracts are entered into for periods consistent with the expected currency transaction exposures, generally three to six months. Any gains and losses on the fair value of these contracts are expected to substantially offset corresponding losses and gains on the underlying transactions.

As of March 31, 2009, we had five currency contracts outstanding involving our Japanese operations with notional amounts aggregating $2,100. These foreign currency hedges are not considered designated hedging instruments. For the three months ended March 31, 2009 and 2008, we recognized net unrealized gains of $365 and net unrealized losses of $381, respectively, from foreign currency forward contracts. For the nine months ended March 31, 2009 and 2008, we recognized net unrealized gains of $8 and net unrealized losses of $855, respectively, from foreign currency forward contracts. These unrealized losses and unrealized gains are substantially offset by foreign exchange gains and losses on intercompany balances recorded by our subsidiary and are recorded in Miscellaneous income (expense) on our Condensed Consolidated Statements of Operations.

The following table summarizes the fair value of derivative instruments as of March 31, 2009:

 

 

 

 

Derivitives not designated as hedging instruments

 

Balance Sheet Location


 


 

 

 

 

Foreign exchange contracts

 

Prepaid expenses and other

$43

14


Note 15: Income Taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months ended March 31,

 

Nine Months ended March 31,

 

 

 


 


 

 

 

2009

 

2008

 

2009

 

2008

 

 

 


 


 


 


 

 

 

Amount

 

Tax
Rate %

 

Amount

 

Tax
Rate %

 

Amount

 

Tax
Rate %

 

Amount

 

Tax
Rate %

 

 

 


 


 


 


 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax (expense) benefit

 

$

4,908

 

 

25

%

$

(15

)

 

11

%

$

6,345

 

 

26

%

$

(642

)

 

34

%

We recorded a valuation allowance of $1,634 for the three and nine months ended March 31, 2009 for net operating loss carryforwards and research and development credits in Canada and Singapore based on our assessment of the likelihood that we would not be able to realize the tax benefits in the foreseeable future.

We adopted the provisions of FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes,” on July 1, 2007. As a result of this adoption, we recognized a liability for unrecognized income tax benefits of $1,535, an increase in income tax receivables of $616, and a charge of approximately $919 to the July 1, 2007 retained earnings balance. As of the adoption date, we had gross tax-affected unrecognized tax benefits of $1,784, of which $1,168, if recognized, would affect the effective tax rate. Due to our net operating loss carryforwards, we have accrued no interest and penalties for the unrecognized tax benefits; however, our accounting policy is to recognize interest related to unrecognized tax benefits in interest expense. Penalties, if incurred, would be recognized as a component of income tax expense. In the normal course of business, we provide for uncertain tax positions and adjust our unrecognized tax benefits accordingly. For the quarter ended March 31, 2009, we did not recognize an additional liability for uncertain tax positions. The total liability for uncertain tax liabilities was $1,872 at March 31, 2009 and June 30, 2008. We are not aware of any tax positions that would create a significant adjustment to the unrecognized tax benefits during the next twelve months.

We are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. We are no longer subject to U.S. federal income tax audit or tax adjustments for years prior to June 30, 1997. We are no longer subject to state and foreign income tax audit or tax adjustments for years prior to June 30, 2000 and June 30, 2003, respectively. We are currently under a federal income tax audit.

Note 16: Commitments and Contingencies

From time to time, we are subject to certain legal proceedings and claims that arise in the normal course of our business. During the nine months ended March 31, 2009, we recorded a reserve of $1.4 million for potential royalty claims. In the opinion of management, any excess settlement of the royalty claims above the amount recorded is not expected to have an adverse effect on our financial condition, results of operation, or liquidity.

We are aware of certain levels of contamination on our property which are below reportable levels. In addition, we are aware of certain contamination on an adjacent property that we formerly owned. The future effect of environmental matters, including potential liabilities, is often difficult to estimate. Presently, we are unable to determine or reasonably estimate the amount of costs, if any, that we might incur or for which we may potentially be responsible. We will record an environmental reserve when it is both probable that a liability has been incurred and the amount of any liability can be reasonably estimated, whether a claim has been asserted or unasserted.

15


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

OVERVIEW

Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics, and electro-optical design and manufacturing services, serving customers in the semiconductor capital equipment and industrial markets. We conduct the majority of our manufacturing in our 153,500 square foot facility in Middlefield, Connecticut and our 39,780 square foot facility in Tucson, Arizona.

On April 2, 2009, Electro Scientific Industries, Inc. (“ESI”) and ZYGO agreed to terminate their previously executed merger agreement. Pursuant to the terms of the settlement agreement, ZYGO agreed to pay ESI a break up fee of $5.4 million, and an additional $1.2 million in the event that on or before November 2, 2009, ZYGO’s Board of directors approves an alternate transaction proposal for the merger or sale of the company. A reevaluation of the proposed merger with ESI by ZYGO’s Board was necessitated by changes in conditions since the merger agreement was executed on October 15, 2008, and led to the withdrawal by the ZYGO Board of its recommendation in favor of the merger agreement.

Orders for the three months ended in March 31, 2009 were $15.6 million, as compared with $39.1 million for the comparable prior year period. Orders for our company’s Metrology Solutions segment accounted for 44% of the orders received, with the Optical Systems segment accounting for 56% of orders. The $25.8 million decline in orders from the same period of the prior year occurred primarily in the Metrology Solutions segment, which experienced reduced orders for instruments of $9.9 million, display solutions of $8.3 million, lithography products of $7.7 million, and vision systems of $1.0 million, slightly offset by an increase in orders of $1.1 million in the semiconductor solutions business. Within the Optics segment, orders increased by $2.3 million, primarily due to an increase in orders of laser fusion optics of $2.7 million and contract manufacturing of $1.0 million, partially offset by a decline in orders in precision optics of $1.4 million. We also experienced a decrease of 48% in sales for the three months ended March 31, 2009 as compared with the prior year period, primarily as a result of the global economic downturn.

Demand for certain of our products is impacted by various conditions affecting all our markets. The downturn in the semiconductor market, in particular, affects all of our Metrology Solutions segment product lines in varying degrees. The length and severity of the current downturn in the semiconductor industry is difficult to predict. Based on recent communications with our semiconductor customers and revised external market forecasts, we believe that there will be continued pressure on demand for several of our products at least through the end of fiscal 2009.

In response to the decline in sales and orders, we have taken and continue to take various actions to mitigate the effects on our company of the downturn in the global economy, including reductions in work force, salary adjustments, unpaid furloughs, suspension of our matching 401-K program, and a reduction in director fees. These actions are expected to save us approximately $9.6 million on an annualized basis. We are also discussing partnership opportunities with established semiconductor equipment manufacturers to combine the strength of our core semiconductor technology with a partner’s strength in the system automation, sales, and service of high volume manufacturing equipment. Pending a successful conclusion of ongoing discussions with semiconductor equipment manufacturers, we could achieve another $4.0 - $5.0 million of annualized cost savings. There may be further restructuring actions and related charges.

16


CRITICAL ACCOUNTING POLICIES, SIGNIFICANT JUDGMENTS, AND ESTIMATES

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosures at the date of our condensed consolidated financial statements. On an on-going basis, management evaluates its estimates and judgments, including those related to bad debts, inventories, marketable securities, warranty obligations, income taxes, long-lived assets, and share-based payments. Management bases its estimates and judgments on historical experience and current market conditions and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. As discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2008, as amended by Form 10-K/A, management considers the Company’s policies on revenue recognition and allowance for doubtful accounts; inventory valuation; other than temporary impairment of marketable securities; share-based compensation; warranty costs; accounting for income taxes; valuation of long-lived assets; and accruals for health insurance to be critical accounting policies due to the estimates, assumptions, and application of judgment involved in each.

As discussed below and in Note 4 to the Condensed Consolidated Financial Statements, we adopted the provisions of Financial Accounting Standards Board Statement of Financial Accounting Standards No. 157, “Fair Value Measurements” (“SFAS 157”) (with the exception of the application of the statement to non-recurring non-financial assets and non-financial liabilities). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. The provisions of SFAS 157 were effective for our fiscal year beginning July 1, 2008. The adoption of the provisions of SFAS 157 did not have a material effect on us.

As discussed below and in Note 14 to the Condensed Consolidated Financial Statements, we adopted the provisions of Financial Accounting Standards Board Statement of Financial Accounting Standards No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133” (“SFAS 161”) during the third quarter of fiscal 2009. SFAS 161 requires entities to provide enhanced disclosure about how and why the entity uses derivative instruments, how the instruments and related hedged items are accounted for under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” and how the instruments and related hedged items affect the financial position, results of operations, and cash flows of the entity. The adoption of the provisions of SFAS 161 did not have a material effect on us.

17


RESULTS OF OPERATIONS

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 

 


 


 

(Dollars in millions)

 

 

Amount

 

Net Sales
%

 

Amount

 

Net Sales
%

 


 

 


 


 


 


 

Quarter ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

13.9

 

 

70

%

$

24.4

 

 

63

%

 

Optical Systems

 

 

6.1

 

 

30

%

 

14.1

 

 

37

%

 

 

 



 



 



 



 

 

Total

 

$

20.0

 

 

100

%

$

38.5

 

 

100

%

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

66.1

 

 

72

%

$

73.5

 

 

67

%

 

Optical Systems

 

 

25.8

 

 

28

%

 

37.0

 

 

33

%

 

 

 



 



 



 



 

 

Total

 

$

91.9

 

 

100

%

$

110.5

 

 

100

%

 

 

 



 



 



 



 

Overall, net sales for the three months ended March 31, 2009 decreased 48% as compared with the prior year period, reflecting decreases in the Metrology Solutions segment sales of 43% and in Optical Systems segment sales of 57%. The decrease in Metrology Solutions segment net sales was primarily due to volume decreases in lithography of $6.5 million, instruments of $1.6 million, display solutions of $1.6 million, and semiconductor solutions of $0.6 million. These volume decreases, in large measure, are due to a reduction in orders that appears to be tied directly to the general global economic downturn, most notably in the semiconductor industry. A decrease in orders from Canon accounted for the majority of the decrease in lithography sales. The decrease in the Optical Systems segment sales occurred across all operations but was the most pronounced in contract manufacturing and laser fusion, which had decreases of $4.6 million and $2.3 million, respectively. The decrease in contract manufacturing sales is primarily related to reductions in shipments for certain medical device equipment and a reduction in engineering projects.

Net sales for the nine months ended March 31, 2009 decreased 17% as compared with the prior year period, reflecting a decrease in the Metrology Solutions segment sales of 10% and a decrease in Optical Systems segment sales of 30%. The Metrology Solutions segment net sales decrease was primarily due to decreased volume in lithography of $7.5 million and in instruments of $4.3 million, partially offset by sales increases in display solutions of $2.9 million and vision systems of $2.0 million. Vision systems was acquired in February of 2008 resulting in only one month of vision systems sales being included in the third quarter of fiscal 2008.The decrease in the Optical Systems segment net sales was due primarily to decreases in contract manufacturing of $6.8 million and volume decreases of $4.4 million in the laser fusion and precision optics areas. The decrease in contract manufacturing sales was primarily due to a reduction in engineering projects and the volume loss on product manufacturing.

Sales in U.S. dollars for the three and nine months ended March 31, 2009 were approximately 80% and 77% of total net sales, respectively, with the remaining 20% and 23%, respectively, being in Euro or Yen. For our sales which are based in foreign currency, we are exposed to foreign exchange fluctuations from the time customers are invoiced in foreign currency until collection occurs. Significant changes in the values of foreign currencies relative to the value of the U.S. dollar, or in the general economic conditions in our export markets, could materially impact the sales of our products in these markets and our Condensed Consolidated Financial Position and Results of Operations.

18


Gross Profit by Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 


 


 

(Dollars in millions)

 

Amount

 

Gross
Profit %

 

Amount

 

Gross
Profit %

 


 


 


 


 


 

Quarter ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

2.5

 

 

18

%

$

11.3

 

 

46

%

 

Optical Systems

 

 

0.7

 

 

11

%

 

4.2

 

 

30

%

 

 

 



 



 



 



 

 

Total

 

$

3.2

 

 

16

%

$

15.5

 

 

40

%

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

27.0

 

 

41

%

$

33.5

 

 

46

%

 

Optical Systems

 

 

5.2

 

 

20

%

 

9.7

 

 

26

%

 

 

 



 



 



 



 

 

Total

 

$

32.2

 

 

35

%

$

43.2

 

 

39

%

 

 

 



 



 



 



 

Gross profit as a percentage of net sales for the three months ended March 31, 2009 was 16%, which represents a decrease of twenty-four percentage points from the comparable prior year period. Within the Metrology Solutions segment, the decrease in gross profit as a percentage of net sales for the three months ended March 31, 2009 as compared with the prior year period is primarily due to inventory write-downs and unabsorbed costs due to lower net sales. Significant inventory write-downs totaled $3.3 million, or 17% of net sales, in the three months ended March 31, 2009, related primarily to inventory for semiconductor, display, and vision systems product lines. These inventory write-downs are due to inventory at levels above current forecasted demand for the foreseeable future. Within the Optical Systems segment, the decrease in gross profit as a percentage of net sales for the three months ended March 31, 2009 as compared with the prior year period is primarily due to unabsorbed costs due to lower net sales. We have taken actions to reduce costs in both segments in light of the decline in orders, including workforce reductions and unpaid furloughs.

Gross profit as a percentage of net sales for the nine months ended March 31, 2009 was 35%, which represents a decrease of four percentage points from the comparable prior year period. Within the Metrology Solutions segment, the decrease in gross profit as a percentage of net sales for the nine months ended March 31, 2009 as compared with the prior year period is primarily due to a change in product mix, inventory write-downs, and unabsorbed costs due to lower net sales. Within the Optical Systems segment, the decrease in gross profit as a percentage of net sales for the nine months ended March 31, 2009 as compared with fiscal 2008 is primarily due to unabsorbed costs due to lower net sales.

Selling, General, and Administrative Expenses (“SG&A”)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 


 


 

(Dollars in millions)

 

Amount

 

% of Sales

 

Amount

 

% of Sales

 


 


 


 


 


 

 

Quarter ended March 31

 

$

16.0

 

 

80

%

$

9.3

 

 

24

%

Nine months ended March 31

 

$

37.9

 

 

41

%

$

24.6

 

 

22

%

SG&A expenses increased in the three months ended March 31, 2009 by $6.7 million from the comparable prior year period, primarily due to the accrual of a $5.4 million merger termination fee and of $0.7 million in other related merger costs, $1.2 million in incremental vision systems expenses which only had one month of expenses in the third quarter of fiscal 2008, and $0.9 in intangible assets write-offs related to vision systems. SG&A expenses increased in the nine months ended March 31, 2009 by $13.3 million from the comparable prior year period, primarily due to the accrual of a $5.4 million merger termination fee and of $2.9 million in other merger related costs, the inclusion of $2.2 million of incremental vision systems expenses, $1.4 million in reserves for potential royalty claims, and $0.9 million in intangible asset write-offs related to vision systems. The write-off of customer related intangible assets is due to the downturn in orders to such an extent that the inherent value of the intangible asset is no longer realizable.

19


Research, Development, and Engineering Expenses (“RD&E”)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 


 


 

(Dollars in millions)

 

Amount

 

% of Sales

 

Amount

 

% of Sales

 


 


 


 


 


 

 

Quarter ended March 31

 

$

7.0

 

 

35

%

$

6.2

 

 

16

%

Nine months ended March 31

 

$

18.4

 

 

20

%

$

17.4

 

 

16

%

RD&E for the three and nine months ended March 31, 2009 increased 13% and 6%, respectively, as compared with the prior year periods. The increase in the RD&E expense for the three months ended March 31, 2009, as compared with the prior year period was primarily due to the write-down of technology-related intangible assets of $1.3 million and the inclusion of vision systems for the entire quarter of $0.4 million, partially offset by reductions in RD&E in other product lines totaling $0.9 million. The inclusion of incremental vision systems expenses increased our RD&E costs by $3.2 million, including an intangible write-down of $1.3 million, for the nine months ended March 31, 2009. This increase was partially offset by a reduction in RD&E spending in our lithography group. The reduction in lithography RD&E is related to the slowdown in capital spending in the semiconductor market. RD&E spending in the three and nine months ended March 31, 2009 was concentrated on our semiconductor initiative and core instruments products. The write-off of technology related intangible assets is due to the downturn in orders to such an extent that the inherent value of the intangible asset is no longer realizable.

Provision for Doubtful Accounts and Notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 


 


 

(Dollars in millions)

 

Amount

 

% of Sales

 

Amount

 

% of Sales

 


 


 


 


 


 

 

Quarter ended March 31

 

$

 

 

0

%

$

 

 

0

%

Nine months ended March 31

 

$

1.0

 

 

1

%

$

1.5

 

 

1

%

Provision for doubtful accounts and notes for the nine months ended March 31, 2009 decreased by $0.5 million, as compared with the prior year period, primarily due to changes in the purchase allocation relating to the Solvision asset acquisition in February 2008 which affected the value of the $1.5 million note receivable from Solvision. We originally had loaned $1.5 million to Solvision in October 2007.

Other Income (Expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 


 


 

(Dollars in millions)

 

Amount

 

% of Sales

 

Amount

 

% of Sales

 


 


 


 


 


 

 

Quarter ended March 31

 

$

(0.1

)

 

-1

%

$

0.1

 

 

0

%

Nine months ended March 31

 

$

0.9

 

 

1

%

$

2.1

 

 

2

%

Other income (expense) for the three months ended March 31, 2009 decreased by $0.2 million as compared with the prior year period primarily due to a decrease in investment income. Investment income has declined due to the maturities of our investment portfolio. Other income for the nine months ended March 31, 2009 decreased by $1.2 million from the comparable prior year period, primarily due to decreased investment income of $1.2 million, and mark to market write-downs of $0.5 million on our investment in an auction rate security and a mutual fund related to our deferred compensation program, partially offset by the benefit from a guaranteed dividend payment of $0.3 million related to our German joint venture partner and $0.2 million related to the settlement of a vendor account.

20


Income Tax Benefit (Expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2009

 

Fiscal 2008

 

 

 


 


 

(Dollars in millions)

 

Amount

 

Tax Rate
%

 

Amount

 

Tax Rate
%

 


 


 


 


 


 

 

Quarter ended March 31

 

$

4.9

 

 

25

%

$

 

 

11

%

Nine months ended March 31

 

$

6.3

 

 

26

%

$

(0.6

)

 

34

%

The effective income tax rate for the three months ended March 31, 2009 was 25% as compared with 11% in the comparable prior year period. The 25% effective tax rate in fiscal 2009 was a tax benefit and resulted from taxable losses in comparatively higher tax jurisdictions, reduced by valuation allowances of $1.6 million against various foreign deferred taxes. The 11% effective tax rate in fiscal 2008 was primarily due to higher earnings in comparatively lower tax jurisdictions and the recognition of research and development tax credits with the filing of tax returns, partially offset by the loss of the deduction attributable to the extraterritorial income exclusion, which was repealed effective January 1, 2007. The effective income tax rate for the nine months ended March 31, 2009 was 26% as compared with 34% in the comparable prior year period. The reduction in the effective income tax rate was primarily due to valuation allowance of $1.6 million against various foreign deferred tax assets.

TRANSACTIONS WITH STOCKHOLDER

Sales to Canon Inc., a stockholder, and Canon Sales Co., Inc., a distributor of certain of our products in Japan and a subsidiary of Canon Inc. (collectively referred to as “Canon”), amounted to $3.0 million and $15.1 million (15% and 16% of net sales, respectively) for the three and nine months ended March 31, 2009, respectively, as compared with $8.3 million and $20.6 million (22% and 19% of net sales, respectively) for the three and nine months ended March 31, 2008. Selling prices of products sold to Canon are based, generally, on the terms customarily given to distributors. At March 31, 2009 and June 30, 2008, there were, in the aggregate, $0.2 million and $4.1 million, respectively, of trade accounts receivable from Canon.

LIQUIDITY AND CAPITAL RESOURCES

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing, and financing activities. Our principal source of liquidity is operating cash flows. In addition to operating cash flows, other significant factors that affect our overall management of liquidity include: capital expenditures, customer credit requirements, investments in businesses, expenses related to our initially contemplated merger with ESI, common stock repurchases, and the adequacy of available bank lines of credit.

Recent distress in the financial markets, including extreme volatility in security prices, severely diminished liquidity and credit availability, rating downgrades of certain investments, and declining valuations of others, has had an adverse impact on financial market activities. We have assessed the implications of these factors on our current business and determined that there has not been a significant impact to our financial position, results of operations, or liquidity during the first nine months of fiscal 2009, other than the indirect effect that the current uncertainty in global economic conditions resulting from the recent disruption in credit markets has had on customer demand for our products.

We currently have no debt or lines of credit. In the future, if the need for debt or credit lines arose there is no assurance that we would be able to secure such financing due to the lack of credit availability in the financial markets or our own financial position.

At March 31, 2009, cash and marketable securities were $43.1 million, a decrease of $7.9 million from $51.0 million at June 30, 2008. Our marketable securities consist of corporate bonds ($7.0 million) and a mutual fund ($0.4 million). The credit losses taken by major financial institutions and the reduction in the Federal Reserve rate may have an effect on the valuation of the portfolio and our future interest income.

The composition of our marketable securities by industry sector is as follows: 54% Finance; 14% Utilities; 13% Real Estate, and 19% Other. We hold a total of eight corporate bonds. The largest individual bond has a value at maturity of $1.0 million. We have the ability and intent to hold all the securities to maturity, the last maturity of which is on December 1, 2009. We believe there are no impairments in our investments other than an impairment of $0.6 million on an auction rate security for the nine months ended March 31, 2009. Such auction rate security is valued at $0 at March 31, 2009.

The cash equivalents balance in our money market account, which is invested primarily in U.S. government securities, is $19.0 million as of March 31, 2009. We do not believe there is any risk to liquidity in the money market account, nor are there currently any limits on redemptions.

21


In our third quarter of fiscal 2009, a reduction in workforce resulted in severance payments totaling $0.9 million. It is expected that reductions in workforce, salary adjustments, unpaid furloughs, suspension of our matching 401-K program, and a reduction in director fees will save us approximately $9.6 million on an annualized basis. We are considering implementing further restructuring actions during the fiscal year. In addition, in our fourth quarter of fiscal 2009, we paid a merger termination fee of $5.4 million.

We have nearly $4.0 million of accounts receivable related to our display customers which are overdue. We have agreed to payment terms with several display customers and are in negotiations with other customers. Although we believe such amounts are collectible, our liquidity will be affected by the timing of the receipt of such payments. We have not experienced significant delays in payments from non-display customers, but given economic conditions, it is possible we will experience delays or non-payment issues which would affect our cash flow.

We believe we have sufficient operating flexibility and cash reserves to maintain adequate amounts of liquidity and to meet our future liquidity requirements for at least the next twelve months, although the impact of continued market volatility cannot be predicted.

Cash Flow from Operating Activities

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2009

 

2008

 

 

 


 


 

Net cash flows provided by (used for) operating activities

 

$

(0.2

)

$

9.9

 

Cash flow from operating activities for the first nine months of fiscal 2009 decreased by $10.1 million as compared with the prior year period. This was primarily due to a negative change in net income of $18.5 million, which included merger related costs of $8.3 million, the negative change in inventory related cash flows of $6.3 million, and an increase in receivables of $4.5 million. The change in inventory related cash flows is primarily a result of increasing inventory levels in the nine months ended March 31, 2009 in display systems and semiconductor inventory related to systems in the customer acceptance phase. These decreases in cash flow from operating activities were offset in part by an increase in accounts payable, accrued expenses, and taxes payable of $14.6 million.

Cash Flow from Investing Activities

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2009

 

2008

 

 

 


 


 

Net cash flows provided by investing activities

 

$

11.6

 

$

14.0

 

Cash flows provided by investing activities for the first nine months of fiscal 2009 decreased by $2.4 million as compared with the prior year period. This change was primarily related to a net $6.1 million decrease in proceeds from the maturity of marketable securities, partially offset by $5.6 in acquisition-related uses of cash flow (Solvision) during the same period in the prior year.

Cash Flow from Financing Activities

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2009

 

2008

 

 

 


 


 

Net cash flows used for financing activities

 

$

(1.1

)

$

(20.1

)

Cash flows used for financing activities in the nine months ended March 31, 2009 decreased by $19.0 million as compared with the prior year period. For the nine months ended March 31, 2008, we utilized $20.1 million to repurchase shares of our common stock.

22


OFF-BALANCE SHEET ARRANGEMENTS

We have not created, and are not party to, any special-purpose or off-balance sheet entities for the purpose of raising capital, incurring debt, or operating parts of our business that are not consolidated into our financial statements. We have not guaranteed any obligations of a third party.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes that have occurred in our quantitative and qualitative market risk disclosures during the nine months ended March 31, 2009 except for the ongoing economic crisis which is impacting us through decreased orders and order push-outs by some of our customers. Our exposure to market risk is presented in Item 7a., “Quantitative and Qualitative Disclosures about Market Risk,” of our Annual Report on Form 10-K, as amended by Form 10-K/A, for the year ended June 30, 2008, filed with the Securities and Exchange Commission (the “2008 Annual Report”).

Current uncertainty in global economic conditions resulting from the recent disruption in credit markets poses a risk to the overall economy that could impact customer demand for our products, impact our ability to manage relationships with our customers, suppliers and creditors, or cause supplier or customer disruptions resulting from tighter credit markets, among other risks.

Item 4. Controls and Procedures

The effectiveness of our or any system of disclosure controls and procedures is subject to certain limitations, including the exercise of judgment in designing, implementing, and evaluating the controls and procedures, the assumptions used in identifying the likelihood of future events, and the inability to eliminate misconduct completely. In designing, implementing, and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation, as of the end of the period covered by this report of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon their evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of such period, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed by us in the reports that we file or submit under the Exchange Act and were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred in our most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

23


PART II - Other Information

Item 1A. Risk Factors

In addition to the information set forth below and elsewhere in this report, the reader should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2008 Annual Report, which could materially affect our business, financial condition, or future results. The risks described in our 2008 Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results.

There is no assurance that we would be able to secure financing if the need arose due to the lack of credit availability in the financial markets or our own financial position.

General economic conditions and the related deterioration in the global business environment could have a material adverse effect on our business, operating results and financial condition.

Global consumer confidence has eroded amidst concerns over declining asset values, inflation, volatility in energy costs, geopolitical issues, the availability and cost of credit, rising unemployment, and the stability and solvency of financial institutions, financial markets, businesses and sovereign nations. These concerns have slowed global economic growth and have resulted in recessions in numerous countries, including many of those in North America, Europe and Asia. Recent economic conditions had a negative impact on our results of operations during the third quarter of fiscal 2009 due to reduced customer demand and we expect this trend to continue for the next several fiscal quarters. As these economic conditions continue to persist, or if they worsen, a number of negative effects on our business could result, including customers or potential customers reducing or delaying orders, the insolvency of key suppliers which could result in production delays, the inability of customers to obtain credit, and the insolvency of one or more customers. Any of these effects could impact our ability to effectively manage inventory levels, create unabsorbed costs due to lower net sales, and collect receivables and ultimately decrease our net revenues and profitability.

We are subject to environmental laws and regulations and may have liabilities arising from environmental matters.

We are subject to a variety of environmental regulations relating to the use, storage, discharge, and disposal of hazardous chemicals used during our manufacturing processes. Any failure by us to comply with applicable regulations could subject us to future liabilities or the suspension of production. We are aware of certain levels of contamination on our property which are below reportable levels. In addition, we are aware of certain contamination on an adjacent property that we formerly owned. We are unable to determine or reasonably estimate the amount of costs, if any, that we might incur or for which we may potentially be responsible. In addition, environmental regulations could restrict our ability to expand our facilities or could require us to acquire costly equipment or to incur other significant expenses to comply with such regulations.

24


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about our purchases during the quarter ended March 31, 2009 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Total number of
shares purchased (2)

 

Average price
paid per share

 

Total number of
shares purchased as
part of publicly
announced
plans or programs (1)

 

Approximate dollar
value of shares that
may yet be purchased
under the plans or
programs (in millions)

 


 


 


 


 


 

 

January 1, 2009 - January 31, 2009

 

 

1,629

 

 

5.72

 

 

 

$

5.0

 

February 1, 2009 - February 28, 2009

 

 

3,771

 

 

4.09

 

 

 

$

5.0

 

March 1, 2009 - March 31, 2009

 

 

453

 

 

4.59

 

 

 

$

5.0

 


 

 

 

 

(1)

In August 2007, our Board of Directors authorized the repurchase of up to $25.0 million of our outstanding common stock. During the nine months ended March 31, 2009, there were no repurchases of common stock in the open market. The share repurchases have been effected pursuant to plans in conformity with Rule 10b5-1 under the Securities Exchange Act of 1934. This rule allows public companies to adopt written, pre-arranged stock trading plans when they do not have material, non-public information in their possession. The adoption of this stock trading plan allows us to repurchase our shares during periods when we otherwise might be prevented from doing so under insider trading laws or because of self-imposed trading blackout periods.

 

 

 

 

(2)

Shares were repurchased from certain of our employees in satisfaction of withholding tax obligations arising from the vesting of their restricted stock.

Item 6. Exhibits

 

 

 

(a)

Exhibits:

 

 

 

 

31.1

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

31.2

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

32.1

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

32.2

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

25


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

          Zygo Corporation

 

 


 

 

          (Registrant)

 

 

 

 

 

/s/ J. Bruce Robinson

 

 


 

 

J. Bruce Robinson

 

 

Chairman and Chief Executive Officer

 

 

 

 

 

/s/ Walter A. Shephard

 

 


 

 

Walter A. Shephard

 

 

Vice President, Finance, Chief Financial Officer, and
Treasurer

 

Date: May 11, 2009

26


EXHIBIT INDEX

 

 

31.1

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

31.2

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

32.1

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

32.2

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002